Cabaletta Bio Inc.

NASDAQ: CABA · Real-Time Price · USD
1.71
0.06 (3.64%)
At close: Aug 15, 2025, 3:59 PM
1.71
0.00%
After-hours: Aug 15, 2025, 07:52 PM EDT

Cabaletta Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
145.61M 131.83M 163.96M 170.61M 178.61M 175.29M 193.24M 115.5M 128.07M 93.84M 81.61M 61.16M 47.17M 59.55M 122.22M 118.26M 99.5M 97.28M
Short-Term Investments
49.07M n/a n/a 12.4M 24.61M 48.55M 48.01M 48.89M 48.26M n/a 24.94M 24.73M 49.64M 49.66M n/a 1M 3.31M 4.75M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
2.5M 2.37M 6.23M 2.48M 2.25M 2.37M 1.71M 984K 685K 581K 565K 689K 965K 985K 357K 324K 318K 300K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
3.73M 2.77M 2.71M 2.5M 3.03M 3.63M 3.24M 1.79M 1.24M 1.89M 2.29M n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
198.41M 134.6M 166.68M 185.51M 206.26M 227.48M 244.49M 166.18M 177.57M 95.73M 108.83M 88.17M 98.75M 111.44M 124.54M 120.85M 105.02M 105.76M
Property-Plant & Equipment
23.59M 28.18M 16.08M 16.41M 8.91M 10.61M 7.45M 6.13M 6.38M 7.13M 7.57M 2.81M 2.31M 1.23M 1.44M 1.46M 1.6M 1.23M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
26.09M 30.55M 22.31M 18.89M 11.16M 12.98M 9.16M 7.11M 7.07M 7.71M 8.13M 3.5M 3.27M 2.22M 1.79M 1.79M 1.92M 1.53M
Total Assets
224.5M 165.14M 185.05M 204.41M 217.42M 240.46M 253.65M 173.29M 184.64M 103.45M 116.97M 91.67M 102.02M 113.66M 126.34M 122.64M 106.93M 107.28M
Account Payables
7.19M 6.49M 4.92M 2.18M 4.22M 5.84M 4.55M 3.62M 2.34M 3.96M 2.46M 1.33M 2.45M 3.91M 2.33M 1.71M 2.37M 1.27M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a 3.94M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a 7.4M 3.56M 2.52M 2.18M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
5.51M 3.37M 8.36M 5.15M 20K -4.4M 1.68M 618K -187K 1.04M 1.33M 2.2M 2.44M 2.13M 3.07M 2.61M 2.1M 2.05M
Total Current Liabilities
41.54M 33.99M 27.09M 22.88M 17.9M 17.97M 15.99M 10.62M 8.48M 9.3M 9.49M 5.8M 6.49M 6.93M 8.38M 6.02M 5.6M 3.97M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
4.48M 9.6M 5.63M 7.29M n/a 765K 1.46M 1.75M 2.01M 2.49M 2.96M 1.33M 2.45M 3.91M 2.33M 1.71M 2.37M 1.27M
Total Liabilities
46.02M 43.59M 32.71M 30.17M 17.9M 18.74M 17.45M 12.36M 10.5M 11.8M 12.45M 5.8M 6.49M 6.93M 8.38M 6.02M 5.6M 3.97M
Total Debt
24.89M 28.79M 15.6M 15.22M 7.4M 8.17M 5.02M 4.27M 4.2M 4.67M 5.14M n/a n/a n/a n/a n/a n/a n/a
Common Stock
1K 1K 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Retained Earnings
-430.17M -385.04M -349.1M -316.51M -285.89M -258.28M -233.24M -212.35M -195.9M -181.42M -165.56M -149.87M -138.44M -125.53M -112.59M -98.7M -87.14M -76M
Comprehensive Income
1K n/a n/a 1K -29K -38K 39K -21K -3K n/a -47K -209K -249K -152K n/a n/a 1K 3K
Shareholders Equity
178.48M 121.55M 152.34M 174.24M 199.52M 221.72M 236.2M 160.92M 174.14M 91.65M 104.52M 85.87M 95.53M 106.72M 117.96M 116.61M 101.33M 103.31M
Total Investments
49.07M n/a n/a 12.4M 24.61M 48.55M 48.01M 48.89M 48.26M n/a 24.94M 24.73M 49.64M 49.66M n/a 1M 3.31M 4.75M